Fulcrum Therapeutics, Inc. (FULC) Ownership

$9.22

south_east
-$0.29 (-3.05%)
Day's range
$9.16
Day's range
$9.7

Fulcrum Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 11/14/2025 10.23 M $94.11 M   0.00% 16.36%
SUVRETTA CAPITAL MANAGEMENT, LLC 11/14/2025 5.38 M $49.51 M   5.86% 8.60%
TCG CROSSOVER MANAGEMENT, LLC 11/17/2025 5.25 M $48.30 M   0.00% 8.39%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2025 4.67 M $42.97 M   8.92% 7.47%
BLACKROCK, INC. 11/12/2025 3.71 M $34.10 M   -15.35% 5.93%
VANGUARD GROUP INC 11/07/2025 3.00 M $27.60 M   -4.67% 4.80%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2025 2.43 M $22.37 M   -47.00% 3.89%
BALYASNY ASSET MANAGEMENT L.P. 11/14/2025 1.45 M $13.34 M   8.39% 2.32%
D. E. SHAW & CO., INC. 11/14/2025 1.45 M $13.33 M   23.18% 2.32%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 1.30 M $11.95 M   -5.34% 2.08%
IKARIAN CAPITAL, LLC 11/14/2025 1.29 M $11.86 M   200.85% 2.06%
STATE STREET CORP 11/14/2025 1.06 M $9.78 M   -12.74% 1.70%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 1.00 M $9.24 M   -15.85% 1.61%
ROYAL BANK OF CANADA 11/14/2025 1.00 M $9.21 M   23,633.67% 1.60%
CITADEL ADVISORS LLC 11/14/2025 854.56 K $7.86 M   414.07% 1.37%
BOOTHBAY FUND MANAGEMENT, LLC 11/14/2025 678.41 K $6.24 M   379.86% 1.08%
GOLDMAN SACHS GROUP INC 11/14/2025 586.35 K $5.39 M   -48.72% 0.94%
NORTHERN TRUST CORP 11/14/2025 568.32 K $5.23 M   -7.07% 0.91%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 540.64 K $4.97 M   -4.04% 0.86%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/13/2025 384.14 K $3.53 M   12.14% 0.61%
SCHONFELD STRATEGIC ADVISORS LLC 11/14/2025 366.30 K $3.37 M   79.21% 0.59%
ADAR1 CAPITAL MANAGEMENT, LLC 11/14/2025 341.61 K $3.14 M   540.33% 0.55%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 333.48 K $3.07 M   -14.00% 0.53%
JANE STREET GROUP, LLC 11/14/2025 321.52 K $2.96 M   1,744.95% 0.51%
UBS GROUP AG 11/13/2025 301.16 K $2.77 M   122.74% 0.48%
BESSEMER GROUP INC 11/05/2025 286.99 K $2.64 M   0.00% 0.46%
DEUTSCHE BANK AG\ 11/13/2025 285.33 K $2.63 M   2.18% 0.46%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 248.20 K $2.28 M   216.18% 0.40%
MORGAN STANLEY 11/14/2025 243.84 K $2.24 M   -22.45% 0.39%
BRAIDWELL LP 11/14/2025 219.49 K $2.02 M   100.00% 0.35%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 179.36 K $1.65 M   41.89% 0.29%
AMERICAN CENTURY COMPANIES INC 11/12/2025 152.24 K $1.40 M   15.03% 0.24%
MILLENNIUM MANAGEMENT LLC 11/14/2025 150.87 K $1.39 M   42.74% 0.24%
BANK OF AMERICA CORP /DE/ 11/14/2025 147.21 K $1.35 M   220.10% 0.24%
ABRDN PLC 11/07/2025 137.96 K $1.27 M   135.04% 0.22%
FIDUCIARY TRUST CO 11/14/2025 136.56 K $1.26 M   0.00% 0.22%
J. GOLDMAN & CO LP 11/14/2025 135.00 K $1.24 M   100.00% 0.22%
HRT FINANCIAL LP 11/14/2025 124.92 K $1.15 M   100.00% 0.20%
AMERIPRISE FINANCIAL INC 11/14/2025 124.67 K $1.15 M   100.00% 0.20%
INVESCO LTD. 11/13/2025 123.87 K $1.14 M   -73.66% 0.20%
BANK OF NEW YORK MELLON CORP 11/03/2025 119.16 K $1.10 M   -13.02% 0.19%
GSA CAPITAL PARTNERS LLP 11/07/2025 116.07 K $1.07 M   256.44% 0.19%
NUVEEN, LLC 11/12/2025 112.20 K $1.03 M   -10.04% 0.18%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 11/14/2025 111.58 K $1.03 M   0.00% 0.18%
CAMPBELL & CO INVESTMENT ADVISER LLC 10/28/2025 102.47 K $942.72 K   100.00% 0.16%
EXOME ASSET MANAGEMENT LLC 11/14/2025 98.80 K $908.95 K   -77.80% 0.16%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 95.40 K $877.68 K   -2.25% 0.15%
BARCLAYS PLC 11/12/2025 89.62 K $824.47 K   -20.03% 0.14%
COMMONWEALTH EQUITY SERVICES, LLC 10/22/2025 83.43 K $768.00 K   0.00% 0.13%
SIMPLIFY ASSET MANAGEMENT INC. 10/20/2025 83.23 K $765.75 K   13.78% 0.13%

Fulcrum Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 160 institutional investors and hedge funds held shares of Fulcrum Therapeutics, Inc.. The most heavily invested institutionals were:

RA CAPITAL MANAGEMENT, L.P.: 10.23 M

SUVRETTA CAPITAL MANAGEMENT, LLC: 5.38 M

TCG Crossover Management, LLC: 5.25 M

Nantahala Capital Management, LLC: 4.67 M

BlackRock, Inc.: 3.71 M

VANGUARD GROUP INC: 3 M

86.08% of Fulcrum Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 59.43 M shares in the last 24 months. This purchase volume represents approximately $547.98 M in transactions.